Heike Kaspar

1.7k total citations
57 papers, 1.2k citations indexed

About

Heike Kaspar is a scholar working on Molecular Medicine, Microbiology and Pollution. According to data from OpenAlex, Heike Kaspar has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 20 papers in Microbiology and 15 papers in Pollution. Recurrent topics in Heike Kaspar's work include Antibiotic Resistance in Bacteria (24 papers), Microbial infections and disease research (19 papers) and Pharmaceutical and Antibiotic Environmental Impacts (15 papers). Heike Kaspar is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Microbial infections and disease research (19 papers) and Pharmaceutical and Antibiotic Environmental Impacts (15 papers). Heike Kaspar collaborates with scholars based in Germany, France and United Kingdom. Heike Kaspar's co-authors include Štefan Schwarz, Kristina Kadlec, Joachim Mankertz, Jürgen Wallmann, Geovana Brenner Michael, Andrea T. Feßler, Ralf Ehricht, Stefan Monecke, Corinna Kehrenberg and Yang Wang and has published in prestigious journals such as Nature Communications, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Heike Kaspar

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heike Kaspar Germany 20 474 293 279 250 243 57 1.2k
Nuno Silva Portugal 19 413 0.9× 323 1.1× 274 1.0× 322 1.3× 155 0.6× 39 1.1k
Andrea Luppi Italy 19 536 1.1× 358 1.2× 199 0.7× 288 1.2× 239 1.0× 67 1.6k
Kanako Ishihara Japan 25 573 1.2× 467 1.6× 274 1.0× 347 1.4× 189 0.8× 67 1.6k
Lourdes Migura‐García Spain 25 552 1.2× 555 1.9× 396 1.4× 303 1.2× 142 0.6× 66 1.6k
Daniela Costa Spain 15 452 1.0× 293 1.0× 190 0.7× 262 1.0× 99 0.4× 16 883
Geovana Brenner Michael Germany 21 570 1.2× 140 0.5× 203 0.7× 275 1.1× 141 0.6× 31 1.0k
Tariq Ali China 21 303 0.6× 264 0.9× 347 1.2× 126 0.5× 168 0.7× 46 1.2k
Philip T. L. C. Clausen Denmark 10 505 1.1× 277 0.9× 587 2.1× 156 0.6× 93 0.4× 23 1.4k
Akemi Kojima Japan 22 666 1.4× 334 1.1× 139 0.5× 397 1.6× 198 0.8× 58 1.4k
Christiane Werckenthin Germany 22 448 0.9× 751 2.6× 488 1.7× 153 0.6× 338 1.4× 57 1.5k

Countries citing papers authored by Heike Kaspar

Since Specialization
Citations

This map shows the geographic impact of Heike Kaspar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Kaspar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Kaspar more than expected).

Fields of papers citing papers by Heike Kaspar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Kaspar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Kaspar. The network helps show where Heike Kaspar may publish in the future.

Co-authorship network of co-authors of Heike Kaspar

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Kaspar. A scholar is included among the top collaborators of Heike Kaspar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Kaspar. Heike Kaspar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamudio, Roxana, Patrick Boerlin, Michael R. Mulvey, et al.. (2024). Global transmission of extended-spectrum cephalosporin resistance in Escherichia coli driven by epidemic plasmids. EBioMedicine. 103. 105097–105097. 10 indexed citations
4.
Schwarz, Štefan, Wolfgang Bäumer, Andrea T. Feßler, et al.. (2024). Critical assessment of commercially available microtitre panels for antimicrobial susceptibility testing of veterinary pathogens. Journal of Antimicrobial Chemotherapy. 80(2). 319–321.
5.
Hanke, Dennis, et al.. (2024). Genetic basis of macrolide resistance in porcine Pasteurella multocida isolates from the German national resistance monitoring program GERM-Vet 2008–2021. Journal of Antimicrobial Chemotherapy. 79(11). 2975–2979. 1 indexed citations
6.
Duijkeren, Engeline van, Merja Rantala, Damien Bouchard, et al.. (2023). The use of aminopenicillins in animals within the EU, emergence of resistance in bacteria of animal and human origin and its possible impact on animal and human health. Journal of Antimicrobial Chemotherapy. 78(8). 1827–1842. 4 indexed citations
7.
Werner, Guido, Muna Abu Sin, Andrea T. Feßler, et al.. (2023). Therapierelevante Antibiotikaresistenzen im One-Health-Kontext. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 66(6). 628–643. 1 indexed citations
9.
Zamudio, Roxana, Patrick Boerlin, Racha Beyrouthy, et al.. (2022). Dynamics of extended-spectrum cephalosporin resistance genes in Escherichia coli from Europe and North America. Nature Communications. 13(1). 7490–7490. 35 indexed citations
10.
Costa, Sofia Santos, Andrea T. Feßler, Anne‐Kathrin Schink, et al.. (2021). Proposal of Epidemiological Cutoff Values for Apramycin 15 μg and Florfenicol 30 μg Disks Applicable to Staphylococcus aureus. Microbial Drug Resistance. 27(11). 1555–1559. 3 indexed citations
11.
Eckmanns, Tim, Heike Kaspar, Roswitha Merle, et al.. (2021). Cluster analysis of resistance combinations in Escherichia coli from different human and animal populations in Germany 2014-2017. PLoS ONE. 16(1). e0244413–e0244413. 11 indexed citations
12.
Kaspar, Heike, et al.. (2020). Phenotypical antimicrobial resistance data of clinical and non-clinical Escherichia coli from poultry in Germany between 2014 and 2017. PLoS ONE. 15(12). e0243772–e0243772. 14 indexed citations
13.
Feßler, Andrea T., Heike Kaspar, Cynthia J. Lindeman, et al.. (2016). Proposal for agar disk diffusion interpretive criteria for susceptibility testing of bovine mastitis pathogens using cefoperazone 30μg disks. Veterinary Microbiology. 200. 65–70. 3 indexed citations
14.
Meemken, Diana, et al.. (2015). Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes. PLoS ONE. 10(8). e0135703–e0135703. 37 indexed citations
15.
Kaspar, Heike, et al.. (2015). Susceptibility testing of Rhodococcus equi: An interlaboratory test. Veterinary Microbiology. 194. 30–35. 5 indexed citations
17.
Feßler, Andrea T., Heike Kaspar, Cynthia J. Lindeman, et al.. (2011). A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens. Veterinary Microbiology. 157(1-2). 226–231. 18 indexed citations
18.
Kernt, Marcus, Christoph Hirneiß, Aljoscha S. Neubauer, et al.. (2010). Moxifloxacin intrakameral: Eine sichere Option zur Endophthalmitisprophylaxe? : In-vitro-Sicherheitsprofil zur intraokularen Anwendung (Originalien). Der Ophthalmologe. 107(8). 720–727. 1 indexed citations
19.
Strauch, Eckhard, Heike Kaspar, Christoph Schaudinn, et al.. (2006). Analysis of Enterocoliticin, a Phage Tail-like Bacteriocin. Kluwer Academic Publishers eBooks. 529. 249–252. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026